La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Brain (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Brain (immunology) < Brain (metabolism) < Brain (pathology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 122.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000024 (1999) D C Vines [Canada] ; B D Ivo ; J R Ballinger ; M. IchiseExternal radioactive reference markers in SPECT imaging of the dopamine system.
000031 (1999) M O Hebb [Canada] ; H A RobertsonMotor effects and mapping of cerebral alterations in animal models of Parkinson's and Huntington's diseases.
000033 (1999) C M Anderson [Canada] ; S A Baldwin ; J D Young ; C E Cass ; F E ParkinsonDistribution of mRNA encoding a nitrobenzylthioinosine-insensitive nucleoside transporter (ENT2) in rat brain.
000095 (2000) F. Calon [Canada] ; M. Morissette ; M. Goulet ; R. Grondin ; P J Blanchet ; P J Bédard ; T. Di Paolo125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
000100 (2000) M. Aschner [États-Unis]Manganese: brain transport and emerging research needs.
000102 (2000) R. De La Fuente-Fernández [Canada] ; A. Kishore ; D B Calne ; T J Ruth ; A J StoesslNigrostriatal dopamine system and motor lateralization.
000104 (2000) O G Rousset [Canada] ; P. Deep ; H. Kuwabara ; A C Evans ; A H Gjedde ; P. CummingEffect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
000150 (2001) R. De La Fuente-Fernández [Canada] ; J Q Lu ; V. Sossi ; S. Jivan ; M. Schulzer ; J E Holden ; C S Lee ; T J Ruth ; D B Calne ; A J StoesslBiochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover.
000160 (2001) A. DagherFunctional imaging in Parkinson's disease.
000180 (2001) W R Martin [Canada]Magnetic resonance imaging and spectroscopy in Parkinson's disease.
000201 (2002) Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández ; James E. Holden ; Doris J. Doudet ; Jess Mckenzie ; A J Stoessl ; T J RuthIncrease in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
000214 (????) Timothy Othman [Canada] ; Dallas Legare ; Parissa Sadri ; W Wayne Lautt ; Fiona E. ParkinsonA preliminary investigation of the effects of maternal ethanol intake during gestation and lactation on brain adenosine A(1) receptor expression in rat offspring.
000259 (2003) Stephen J. Kish [Canada]Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
000260 (2003) A. Hadj Tahar [Canada] ; R. Grondin ; L. Grégoire ; F. Calon ; T. Di Paolo ; P J BédardNew insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
000261 (2003) A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
000263 (2003) Ajit Kumar [Canada] ; Zhigao Huang ; Raúl De La Fuente-FernándezMechanisms of motor complications in treatment of Parkinson's disease.
000284 (2003) Frédéric Calon [Canada] ; Marc Morissette ; Ali H. Rajput ; Oleh Hornykiewicz ; Paul J. Bédard ; Thérèse Di PaoloChanges of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications.
000301 (2003) Jocelyn KaiserManganese: a high-octane dispute.
000319 (2003) Fiona E. Parkinson [Canada] ; Jessica Friesen ; Ljiljana Krizanac-Bengez ; Damir JanigroUse of a three-dimensional in vitro model of the rat blood-brain barrier to assay nucleoside efflux from brain.
000343 (1992) J. Mclaurin [Canada] ; G. Hashim ; M A MoscarelloAn antibody specific for component 8 of myelin basic protein from normal brain reacts strongly with component 8 from multiple sclerosis brain.
000351 (1992) R F Peppard [Canada] ; W R Martin ; G D Carr ; E. Grochowski ; M. Schulzer ; M. Guttman ; P L Mcgeer ; A G Phillips ; J K Tsui ; D B CalneCerebral glucose metabolism in Parkinson's disease with and without dementia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Brain (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Brain (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Brain (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022